[Synthesis and anti-tumor activity of oleanolic acid derivatives]

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Oleanolic acid (OA) is a natural triterpenoid with known biological activities.
• Modifications of natural products can lead to enhanced therapeutic properties.
• Developing novel anticancer agents is a critical area of research.

Purpose of the Study:

• To design and synthesize novel oleanolic acid derivatives.
• To evaluate the in vitro cytotoxic activity of these derivatives against various cancer cell lines.
• To identify potent anticancer compounds for further investigation.

Main Methods:

• Synthesis of thirteen novel oleanolic acid derivatives with modifications at C-3, C-12, and C-28 positions.
• Structural characterization using Mass Spectrometry (MS), 1H Nuclear Magnetic Resonance (NMR), and elemental analysis.
• In vitro cytotoxicity evaluation using MTT assay against SGC7901 (gastric), MCF-7 (breast), and A549 (lung) cancer cell lines.

Main Results:

• All synthesized OA derivatives exhibited enhanced cell growth inhibitory activity compared to the parent OA.
• Compounds II2 and II3 displayed potent cytotoxicity against MCF-7 and A549 cancer cells.
• The cytotoxic potency of II2 and II3 exceeded that of gefitinib, a standard positive control, against these cell lines.

Conclusions:

• The novel oleanolic acid derivatives possess significant in vitro anticancer potential.
• Compounds II2 and II3 represent promising lead compounds for the development of new cancer therapeutics.
• Further preclinical studies are warranted to explore the therapeutic efficacy and mechanisms of action of these derivatives.